EXLINKIBART
UNII 23C7TO9S06

Substance Identification & Data

This profile provides standardized clinical and technical data for Exlinkibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23C7TO9S06.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2642171-64-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
23C7TO9S06
CAS Registry Number
2642171-64-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EXLINKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12376
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Exlinkibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EXLINKIBART

Common Names & Synonyms

EXLINKIBART [INN]
IMMUNOGLOBULIN G1 (DE-236-GLYCINE,267-GLUTAMIC ACID,DE-C-TERMINAL LYSINE), ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR TNFRSF9) (HUMAN-MUS MUSCULUS MONOCLONAL LVGN6051 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LVGN6051 .KAPPA.-CHAIN, DIMER
LVGN 6051 [WHO-DD]

Technical Codes

LVGN-6051